Literature DB >> 20022218

Smoking initiation and schizophrenia: a replication study in a Chinese Han population.

Xiang Yang Zhang1, Cun Bao Li, Min Li, You Lan Zheng, Chong Xi Zhang, Quan Zhi Yan, Wen Zhong Liu, Yi Min Kang, Fan Wang, Da Chun Chen, Mei Hong Xiu, Thomas R Kosten.   

Abstract

Schizophrenia is associated with a greater probability of ever smoking daily and with higher rates of initiation of daily smoking after age 20 in Caucasian populations. The aims of the current study were to replicate that schizophrenia is associated with smoking and higher risk of initiating daily smoking before schizophrenia starts among a large sample of male Chinese patients. A survival analysis of onset age for daily smoking compared 776 DSM-IV male inpatients with schizophrenia to 560 male controls. The results showed that the cumulative hazard curves for age of smoking initiation in schizophrenia and controls were significantly different (p<0.001), even after controlling for education (p<0.001). After excluding the patients who started smoking within 5 years before schizophrenia started, the cumulative hazard curve for schizophrenia was significantly different from ever-smoked controls (p<0.001), even after adjusting for education (p<0.001). These findings suggest that schizophrenic patients have a higher risk of starting daily smoking suggesting that vulnerability to schizophrenia may be associated with a higher risk of becoming a daily smoker. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20022218     DOI: 10.1016/j.schres.2009.11.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.

Authors:  Luyao Xia; Lei Liu; Xiaohong Hong; Dongmei Wang; Gaoxia Wei; Jiesi Wang; Huixia Zhou; Hang Xu; Yang Tian; Qilong Dai; Hanjing E Wu; Catherine Chang; Li Wang; Thomas R Kosten; Xiang Yang Zhang
Journal:  Neuropsychopharmacology       Date:  2020-04-29       Impact factor: 7.853

Review 2.  Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

3.  Clinical characteristics of heavy and non-heavy smokers with schizophrenia.

Authors:  Heidi J Wehring; Fang Liu; Robert P McMahon; Kristen M Mackowick; Raymond C Love; Lisa Dixon; Deanna L Kelly
Journal:  Schizophr Res       Date:  2012-05-10       Impact factor: 4.939

4.  The effect of nicotine dependence on psychopathology in patients with schizophrenia.

Authors:  Anne Yee; Nik Nasyrah Bt Nek Mohamed; Aili Hanim Binti Hashim; Huai Seng Loh; Manveen Kaur Harbajan Singh; Chong Guan Ng; S T Jambunathan
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

Review 5.  Does tobacco use cause psychosis? Systematic review and meta-analysis.

Authors:  Pedro Gurillo; Sameer Jauhar; Robin M Murray; James H MacCabe
Journal:  Lancet Psychiatry       Date:  2015-07-09       Impact factor: 27.083

6.  Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy.

Authors:  Yan-Min Xu; Hong-Hui Chen; Fu Li; Fang Deng; Xiao-Bo Liu; Hai-Chen Yang; Li-Guo Qi; Jin-Hong Guo; Tie-Bang Liu
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.